STAT published the first part today of a series on a trend we have watched arrive: cash-pay longevity clinics inside nonprofit academic hospitals, naming Northwestern, Weill Cornell and the Mayo Clinic. The reporter bought Northwestern's $5,500 annual package and went through it — VO2 max, a bone-density scan, assessments of heart, brain, lungs, eyes, ears, strength and fitness. Weill Cornell's own program page lists a $12,000 one-year program and a $7,500 baseline assessment, with labs billed separately and a note that longevity programs are elective and not covered by insurance. STAT's piece quotes critics asking how five-figure out-of-pocket programs fit a nonprofit mission, and warning that some of the tests lack evidence of improving health. When the longevity industry was startups, we called it the longevity industrial complex. It now has a hospital wing.
Sort the package. Some of what is inside is medicine with evidence, available for far less: blood pressure, lipids and glucose from a primary-care visit; a bone-density scan when guidelines call for one; a fitness assessment that any track and a stopwatch approximates. Some is measurement for its own sake — a VO2 max number is a fine thing to know and changes nothing a brisk walk would not. And some is screening whose benefit is unproven: Weill Cornell's program includes a multi-cancer blood test, a technology still being tested in trials for whether finding cancers earlier this way saves lives. The page justifying the package cites "numerous studies across millions of patients" for the claim that fitness predicts longevity better than any other metric, without naming one. The claim is roughly right. The habit of asserting it without a citation, on a $12,000 brochure, is the one we want you to notice.
Ben’s takeHospitals are doing this because the margin is there and the customer is already convinced: the recovering optimizer we write for has been trained by a decade of startups to want this, and now a trusted institution will sell it with a better logo. That is the endpoint of the longevity trap — the brand that should be telling you the fundamentals are free is instead packaging them at $5,500 and calling it medicine. Nonprofit status is a tax question. The evidence question is unchanged.
Loree’s takeI want to be fair to the clinicians in these programs; many of them will tell patients to sleep, move, eat real food and see their friends, which is correct. My objection is to the price of hearing it and to the tests around it. A patient who pays $12,000 expects to be found something, and a panel that broad will oblige. The best outcome of a longevity visit is the sentence "you are fine, go live" — and that sentence is hard to charge for.
Why it matters to a recovering optimizer. This is the equity argument in its sharpest form. Health systems that serve everyone are opening a door marked longevity that only some can walk through, for services whose evidence-based core — measurement of the fundamentals and advice to practice them — is already available to every patient for the cost of a visit. A long healthy life should not depend on income or zip code. A $5,500 package behind a nonprofit's name does not change that principle. It tests it.
Everything in the package with evidence is in a standard visit. Ask your doctor for those, and spend the $5,500 on thirty years of groceries and shoes.
This post reports on evidence and expert disagreement. It is not medical advice; decisions about treatment belong with you and your clinician.